Novel Role of the CXC Chemokine Receptor 3 in Inflammatory Response to Arterial Injury: Involvement of mTORC1: Retraction
The authors of the following article have requested that it be retracted from publication in Circulation Research:
Schwarz JB, Langwieser N, Langwieser NN, Bek MJ, Seidl S, Eckstein HH, Lu B, Schömig A, Pavenstädt H, Zohlnhöfer D. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circ Res. 2009;104:189–200.
Dr Johannes Schwarz admitted to manipulating in vitro data concerning IP-10–induced effects in T cells and SMCs (Figure 1 and Figure 8e). All coauthors involved in this study, other than Dr Schwarz, had no knowledge of any scientific impropriety related to the collection, analysis, or presentation of these in vitro data in this manuscript. Dr Schwarz apologizes for any adverse consequences that may have resulted from the article's publication and any inconvenience and wasted effort that this may have caused the scientific community and readers of the journal.
- © 2011 American Heart Association, Inc.
- Schwarz JB,
- Langwieser N,
- Langwieser NN,
- Bek MJ,
- Seidl S,
- Eckstein HH,
- Lu B,
- Schömig A,
- Pavenstädt H,
- Zohlnhöfer D